Prevalence Rates of Pathogenic Mutations in the BRCA1 and BRCA2 Genes in Families with Different Disease Histories: Results from the German Consortium for Hereditary Breast and Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, February 11, 2010

Prevalence Rates of Pathogenic Mutations in the BRCA1 and BRCA2 Genes in Families with Different Disease Histories: Results from the German Consortium for Hereditary Breast and Ovarian Cancer



* From 1997-2009 more than 6,000 families were screened for pathogenic mutations in BRCA1/2.


* Mutation analysis was performed by DHPLC (denaturing high-performance liquid chromatography) pre-screening, direct sequencing of suspect fragments and MLPA (multiplex ligation-dependant probe amplification) in at least one index case of these families.

* Complete pedigree information over three generations was used for the analysis.

* The highest mutation prevalence rate (78%) was seen in families with at least two relatives affected by pre-menopausal breast cancer and at least two affected by ovarian cancer at any age.

* Importantly, the presence of a single woman affected by breast and ovarian cancer or bilateral breast cancer with first breast cancer under the age of 41 was associated with a BRCA1/2 mutation prevalence of 53% (59%) and 34%) respectively.

* Interestingly, low mutation prevalence rates of <10%> with only one case of male breast cancer (9%), and in families with three or more cases of postmenopausal breast cancer (7%), the former being only BRCA2 mutations.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.